Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AMPH
AMPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMPH News
Amphastar's Floyd Petersen Sells 16,679 Shares for $441,836
Dec 23 2025
Fool
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
ETFs on the Move This Monday: IHE, BLOK
Dec 15 2025
NASDAQ.COM
Amphastar Pharmaceuticals Receives FDA Approval for Teriparatide Injection Device
Dec 15 2025
Newsfilter
Amphastar announces FDA approval for teriparatide injection.
Dec 15 2025
SeekingAlpha
CRMD Surges Over 40% Year-to-Date: Should You Buy, Sell, or Hold?
Dec 11 2025
NASDAQ.COM
Amphista Unveils AMX-883, Paving New Treatment Path for Acute Myeloid Leukaemia
Dec 08 2025
Globenewswire
Amphastar (AMPH) Third Quarter 2025 Earnings Call Summary
Nov 28 2025
NASDAQ.COM
Breaking Down the Components: IJR Aims for $140
Nov 11 2025
NASDAQ.COM
Daily Upgrade Report for Validea's Peter Lynch Strategy - November 11, 2025
Nov 11 2025
NASDAQ.COM
Amphastar Pharmaceuticals Inc (AMPH) Q3 2025 Earnings Call Summary: Robust Performance of Core Products
Nov 08 2025
Yahoo Finance
Needham Keeps Buy Rating on Amphastar Pharma, Reduces Price Target to $34
Nov 07 2025
Benzinga
Are Predictions from the Options Market Indicating a Surge in Amphastar Pharmaceuticals Stock?
Sep 02 2025
NASDAQ.COM
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
Aug 12 2025
Benzinga
Amphastar (AMPH) Q2 2025 Earnings Call Transcript
Aug 07 2025
NASDAQ.COM
Amphastar: Q2 Earnings Snapshot
Aug 07 2025
Yahoo Finance
Show More News
